ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
1 hedge funds and large institutions have $9K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-4
Holders Change %
-80%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$9K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$186K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$147K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$79K |
| 4 |
Morgan Stanley
New York
|
-$17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Simplex Trading
Chicago,
Illinois
| $9K | +$9K | +1,026 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$186K | -20,322 | Closed |
|
|
3
Citadel Advisors
Miami,
Florida
| – | -$147K | -16,056 | Closed |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | -$79K | -8,651 | Closed |
|
|
5
Morgan Stanley
New York
| – | -$17K | -1,905 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$12K | -1,346 | Closed |
|